|
|
 |
|
Viewing report
|
|
|
|
Melanoma Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., April 2010, Pages: 615
This report analyzes the worldwide markets for Melanoma Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets. T
he report profiles 73 companies including many key and niche players such as Abraxis BioScience, Inc., Astellas Pharma US, Inc., Antigenics Inc., AVAX Technologies, Inc., BioVex, Inc., GenVec, Inc., GlaxoSmithKline Plc., Medarex Inc., Merck KGAA, Oxford Biomedica Plc, Pfizer, Inc., Progen Pharmaceuticals Limited, and Vical Inc.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Human Vaccines - Global Strategic Business Report
The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact
Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market
Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Anti-Infectives - Global Strategic Business Report
Lymphoma Therapeutics - Global Strategic Business Report
Prostate Cancer Therapeutics - Global Strategic Business Report
Bladder Cancer Therapeutics - Global Strategic Business Report
Bipolar Disorder - Global Strategic Business Report
Multiple Sclerosis Therapeutics - Global Strategic Business Report
|
|
|
|
